AAAAAA
Results:
1-13
|
Results: 13
Authors:
Exner, M
Thalhammer-Scherrer, R
Kudlacek, S
Simonitsch, I
Jager, U
Schwarzinger, I
Citation: M. Exner et al., Suspect cell convolutes in the bone marrow of a patient with renal cell carcinoma unmasked as atypical convolutes of hairy cells, LEUK LYMPH, 42(1-2), 2001, pp. 239-241
Authors:
Sperr, WR
Wimazal, F
Kundi, M
Fonatsch, C
Thalhammer-Scherrer, R
Schernthaner, GH
Schwarzinger, I
Haas, OA
Geissler, K
Lechner, K
Valent, P
Citation: Wr. Sperr et al., Survival analysis and AML development in patients with de novo myelodysplastic syndromes: comparison of six different prognostic scoring systems, ANN HEMATOL, 80(5), 2001, pp. 272-277
Authors:
Traunmuller, F
Thalhammer-Scherrer, R
Locker, GJ
Losert, H
Schmid, R
Staudinger, T
Thalhammer, F
Citation: F. Traunmuller et al., Single-dose pharmacokinetics of levofloxacin during continuous veno-venoushaemofiltration in critically ill patients, J ANTIMICRO, 47(2), 2001, pp. 229-231
Authors:
Wimazal, F
Sperr, WR
Kundi, M
Meidlinger, P
Fonatsch, C
Jordan, JH
Thalhammer-Scherrer, R
Schwarzinger, I
Geissler, K
Lechner, K
Valent, P
Citation: F. Wimazal et al., Prognostic value of lactate dehydrogenase activity in myelodysplastic syndromes, LEUK RES, 25(4), 2001, pp. 287-294
Authors:
Ruzicka, K
Veitl, M
Thalhammer-Scherrer, R
Schwarzinger, I
Citation: K. Ruzicka et al., The new hematology analyzer Sysmex XE-2100 - Performance evaluation of a novel white blood cell differential technology, ARCH PATH L, 125(3), 2001, pp. 391-396
Authors:
Laczika, K
Mitterbauer, G
Weltermann, A
Knobl, P
Thalhammer-Scherrer, R
Haas, OA
Lechner, K
Jaeger, U
Citation: K. Laczika et al., Prolonged third remission in a patient with acute promyelocytic leukemia after consolidation chemotherapy with intermittent intermediate dose Ara-C and maintenance with intermittent all-trans retinoic acid (ATRA), LEUK LYMPH, 36(5-6), 2000, pp. 625-629
Authors:
Thalhammer-Scherrer, R
Geissler, K
Schwarzinger, I
Chott, A
Gisslinger, H
Knobl, P
Lechner, K
Jager, U
Citation: R. Thalhammer-scherrer et al., Fludarabine therapy in Waldenstrom's macroglobulinemia, ANN HEMATOL, 79(10), 2000, pp. 556-559
Authors:
Grumbeck, E
Aiginger, P
Gisslinger, B
Geissler, K
Thalhammer-Scherrer, R
Gisslinger, H
Citation: E. Grumbeck et al., Macrocytic anemia and thrombocytosis associated with thymoma: A case report, AM J HEMAT, 63(1), 2000, pp. 38-41
Authors:
Thalhammer-Scherrer, R
Veitl, M
Exner, M
Schneider, B
Geissler, K
Simonitsch, I
Schwarzinger, I
Citation: R. Thalhammer-scherrer et al., Role of immunological lymphocyte subset typing as a screening method for lymphoid malignancies in daily routine practice, CYTOMETRY, 42(1), 2000, pp. 5-10
Authors:
Schmaldienst, S
Traunmuller, F
Burgmann, H
Rosenkranz, AR
Thalhammer-Scherrer, R
Horl, WH
Thalhammer, F
Citation: S. Schmaldienst et al., Multiple-dose pharmacokinetics of cefepime in long-term hemodialysis with high-flux membranes, EUR J CL PH, 56(1), 2000, pp. 61-64
Authors:
Thalhammer-Scherrer, R
Wieselthaler, G
Knoebl, P
Schwarzinger, I
Simonitsch, I
Mitterbauer, G
Berlakovich, GA
Mannhalter, C
Haas, OA
Mayer, G
Muehlbacher, F
Wolner, E
Klepetko, W
Lechner, K
Jaeger, U
Citation: R. Thalhammer-scherrer et al., Post-transplant acute myeloid leukemia (PT-AML), LEUKEMIA, 13(3), 1999, pp. 321-326
Authors:
Mitterbauer, G
Zimmer, C
Fonatsch, C
Haas, OA
Thalhammer-Scherrer, R
Schwarzinger, I
Kahls, P
Jaeger, U
Lechner, K
Mannhalter, C
Citation: G. Mitterbauer et al., Monitoring of minimal residual leukemia in patients with MLL-AF9 positive acute myeloid leukemia by RT-PCR, LEUKEMIA, 13(10), 1999, pp. 1519-1524
Authors:
Thalhammer, F
Traunmuller, F
El Menyawi, I
Frass, M
Hollenstein, UM
Locker, GJ
Stoiser, B
Staudinger, T
Thalhammer-Scherrer, R
Burgmann, H
Citation: F. Thalhammer et al., Continuous infusion versus intermittent administration of meropenem in critically ill patients, J ANTIMICRO, 43(4), 1999, pp. 523-527
Risultati:
1-13
|